Patients with advanced kidney cancer who received an experimental vaccine after their tumors were removed were still ...

Advanced prostate cancer cases are rising sharply in California, outpacing national trends, according to a new study from ...

For men with benign prostatic hyperplasia (BPH), transurethral Holmium Laser of the Prostate (HoLEP) with Double-n Technology ...

A new study by UC San Francisco found that prostate cancer cases are increasing in California, likely due to a change in ...

Caris Life Sciences® (Caris), a leading next-generation AI TechBio company and precision medicine pioneer, announced today ...

It’s been a year since King Charles was diagnosed with cancer on February 5, 2024. Buckingham Palace confirmed the monarch, ...

Published in Cell Reports Medicine, results of a VHIO-led study support the feasibility of using RAD51 testing to complement ...

(RTTNews) - RedHill Biopharma (RDHL) Tuesday announced that it has launched a Phase 2 trial to assess opaganib's ability to enhance darolutamide in treating metastatic castrate-resistant prostate ...

The increasing global prevalence of cancer is fueling the demand for peptide-drug conjugates as targeted therapies, providing improved effectiveness and lower systemic toxicity than conventional ...

The 80-patient placebo-controlled randomized Phase 2 study will evaluate the efficacy of opaganib in combination with Bayer's darolutamide in men with metastatic castrate-resistant ...

RedHill Biopharma (RDHL) announced the initiation of a Phase 2 clinical study to evaluate the efficacy of its opaganib candidate in combination ...

RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced ...